OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - STRYKER CORP. Stock

Certificat

DE000SU9FTN6

Market Closed - Bid/Ask 03:37:47 2024-05-13 pm EDT After market 03:59:45 pm
13.57 EUR +4.79% Intraday chart for OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - STRYKER CORP. 13.58 +0.07%
Current month+8.39%
1 month+11.60%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
24-05-13 13.57 +4.79% 0
24-05-10 12.95 0.00% 0
24-05-09 12.95 -2.19% 0
24-05-08 13.24 +1.77% 0
24-05-07 13.01 -3.63% 0

Real-time Boerse Frankfurt Warrants

Last update May 13, 2024 at 03:37 pm EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SU9FTN
ISINDE000SU9FTN6
Date issued 2024-02-16
Strike 470.9 $
Maturity Unlimited
Parity 10 : 1
Emission price 11.5
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.74
Lowest since issue 9.9
Spread 0.04
Spread %0.29%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW